Jodi Dawson, NP
Adult Health · Ogden, UTNPI 1902405228
Payments from drug & device makers
What this record shows
Medtronic accounts for 73.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $1,662 and has fallen 87.9% since, to $201 in 2025. Among adult health clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $68.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Tandem Diabetes Care, Inc.$155
- BETA Bionics, Inc.$149
- Amgen$122
- Sanofi-aventis U.S. LLC$81
- Lilly USA, LLC$60
- plus $189 from 7 others
What the payments were for
- Travel & lodging$1,68558%
- Food & beverage$1,21042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 16 | $2,140 |
| Tandem Diabetes Care, Inc. | 5 | $155 |
| BETA Bionics, Inc. | 5 | $149 |
| Amgen | 1 | $122 |
| Sanofi-aventis U.S. LLC | 2 | $81 |
| Lilly USA, LLC | 3 | $60 |
| Cequr Corporation | 2 | $49 |
| Novartis | 2 | $38 |
| Dexcom, Inc. | 2 | $35 |
| Lifescan, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $15 |
| Ascensia Diabetes Care US Inc. | 1 | $15 |
| Vapotherm Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$1,668
- EVENITY$122
How this compares
$2,895 in reported general payments places this provider in the 90th percentile of 53 adult health providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 151 | $235,232 |
| MounjaroTirzepatide | 191 | $215,199 |
| JardianceEmpagliflozin | 167 | $202,581 |
| TrulicityDulaglutide | 98 | $127,653 |
| Tresiba Flextouch U-100Insulin Degludec | 60 | $66,855 |
| FarxigaDapagliflozin Propanediol | 57 | $64,664 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 34 | $63,164 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 79 | $58,152 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $48,443 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $46,814 |
| JanuviaSitagliptin Phosphate | 30 | $37,846 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $37,572 |
| RybelsusSemaglutide | 22 | $29,375 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 18 | $29,245 |
| TradjentaLinagliptin | 26 | $24,446 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $60 | $357,332315 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $15 | $271,745197 claims |
| Sanofi-aventis U.S. LLCLantus | $81 | $7,50425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 53 adult health providers in Utah.
Other adult health in Ogden
- Ashleigh RousseauOgden$462
- Kristin LarsonSalt Lake City$75K
- Tomeika Ulett-GarciaAmerican Fork$9K
- Lucinda RossSalt Lake City$4K
- Deborah BartonSaint George$4K
- Rebecca WaiteVineyard$3K
- Joanne NamSalt Lake City$3K
- Irene CheongSalt Lake City$2K
- Emilee KellySt George$2K
- Brighton LovedayProvo$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.